The Chicago Entrepreneur

Moderna’s stock slides 12% after it lowers full-year sales guidance

The second-quarter sales decline was mostly due to lower demand for the company’s COVID-19 vaccine.

Previous post Hershey stock slides on Q2 sales and earnings miss as consumers pull back on discretionary spending
Next post Eli Lilly’s tirzepatide showed positive results in late-stage trial as treatment for heart failure